Plain-English translation of NCT05900414 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new web-based tool called RAPID AFib that helps people with atrial fibrillation (an irregular heartbeat) understand their personal stroke risk and choose the best blood-thinning medication for them. The tool walks you through your individual risk, shows you different medication options, and creates a summary to discuss with your doctor. Researchers want to see if this tool helps patients make better treatment decisions.
Many people with irregular heartbeat don't receive the right stroke prevention treatment, even though blood-thinning medications can prevent most strokes caused by this condition. This tool was created to help close that gap by giving patients clear, personalized information so they can work together with their doctor to choose the treatment that's right for them.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive a web-based tool to review before your upcoming specialist appointment. About half of participants will also get access to the new RAPID AFib decision aid, which helps you understand your stroke risk and compare medication options interactively. You'll work through the tool at your own pace before your clinic visit, then discuss your preferences with your doctor. The study is designed to be short and fit around your normal care schedule.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Canada